MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$8,690,667
EPS
-$2.71
Unit: Dollar

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Research and development
1,376,861 702,601.5* 922,857 1,317,980
General and administrative
1,715,639 1,761,852.5* 1,020,154 1,143,249
Total operating expenses
3,092,500 2,464,454 1,943,011 2,461,229
Loss from operations
-3,092,500 -2,464,454* -1,943,011 -2,461,229
Change in fair value of warrant liability
--1,175.5* -611 -44
Other income (expense), net
83,449 76,966.5* 35,224 16,803
Total other income (expense), net
83,449 78,142* 35,835 16,847
Net loss
-3,009,051 -2,386,312* -1,907,176 -2,444,382
Deemed dividends
5,681,616 -2,975,764* 2,769,742 3,181,786
Net gain attributable to common stockholders
-8,690,667 589,452 -4,676,918 -5,626,168
Basic EPS
-2.71 0.95 -1.77 -7.01
Diluted EPS
-2.71 0.95 -1.77 -7.01
Basic Average Shares
3,207,720 620,785* 2,644,733 802,670
Diluted Average Shares
3,207,720 620,785* 2,644,733 802,670
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net gainattributable to common...-$8,690,667 Other income(expense), net$83,449 Deemed dividends$5,681,616 Net loss-$3,009,051 Total other income(expense), net$83,449 Loss from operations-$3,092,500 Total operatingexpenses$3,092,500 General andadministrative$1,715,639 Research and development$1,376,861

REVELATION BIOSCIENCES, INC. (REVBW)

REVELATION BIOSCIENCES, INC. (REVBW)